Get your full text copy in PDF
Erik A. Kumetz, Jon H. Meyerle, Shayna C. Rivard
(Department of Flight Medicine, 36th Medical Group, Andersen Air Force Base, Yigo, Guam)
Am J Case Rep 2020; 21:e919432
Epidermolysis bullosa acquisita is a rare, subepithelial bullous disorder, which is distinguished from other autoimmune blistering diseases by the production of antibodies against type VII collagen.
CASE REPORT: Here, we describe the case of a 79-year-old male resident of the Northern Mariana Islands who presented to the clinic with multiple blistering skin lesions.
CONCLUSIONS: The primary focus of treatment is to prevent disease progression and serious complications of scarring (including blindness and respiratory obstruction) by avoiding physical trauma and suppressing the immune systems with agents, including corticosteroids, colchicine, dapsone, methotrexate, and cyclophosphamide. Successful treatment of the condition should involve a multidisciplinary team of medical professionals with regular monthly follow-ups during periods of active disease.